share_log

賽生藥業:自願公告 - Vaborem在中國的III期臨床試驗完成首例受試者入組給藥

SCICLONE PHARMA: VOLUNTARY ANNOUNCEMENT - SciClone Announces First Subject Dosed in Phase III Clinical Trial of Vaborem in China

香港交易所 ·  Jul 4, 2023 19:09
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more